Abstract
Several lines of studies have suggested the importance of cortical dopamine (DA) transmission in the pathophysiology of schizophrenia. The putative alteration of striatal D2 receptor density in schizophrenia has been studied intensely, although extrastriatal DA activity may be more relevant for behavioral symptoms. The aim of this study was to explore extrastriatal D2/3 density in drug-naive schizophrenic patients. We studied the extrastriatal D2/3 receptor binding with a novel high-affinity single-photon emission tomography ligand epidepride in seven drug-naive schizophrenic patients and seven matched controls. The symptoms were rated with Positive and Negative Syndrome Scale for Schizophrenia. The findings indicated an extremely low D2/3 receptor binding among patients in temporal cortex in both hemispheres when compared with controls (effect size 2.0–2.3), and the D2/3 levels had negative correlations with general psychopathological (r from −0.86 to −0.90) and negative (r from −0.37 to −0.55) schizophrenic symptoms. These results support the previous hypothesis on dysfunction of mesocortical DA function behind the cognitive and negative symptoms in schizophrenia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Finlay JM . Mesoprefrontal dopamine neurons and schizophrenia of developmental abnormalities. Schizophr Bull 2001; 27: 431–442.
Wong DF, Wagner Jr NH, Tune LE, Dannals RF, Pearlson GD, Links JM et al. Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science 1986; 234: 1558–1563.
Farde L, Wiesel FA, Stone-Elander S, Halldin C, Nordström AL, Hall H et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 1990; 47: 213–219.
Hietala J, Syvälahti E, Vuorio K, Någren K, Lehikoinen P, Ruotsalainen U et al. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 1994; 51: 116–123.
Kuikka JT, Åkerman KK, Hiltunen J, Bergström KA, Räsänen P, Vanninen E et al. Striatal and extrastriatal imaging of dopamine D2 receptors in the living human brain with [123I]epidepride single-photon emission tomography. Eur J Nucl Med 1997; 24: 483–487.
Suhara T, Okubo Y, Yasuno F, Sudo Y, Inoue M, Ichimiya T et al. Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia. Arch Gen Psychiatry 2002; 59: 25–30.
Okubo Y, Suhara T, Suzuki K, Kobayashi K, Inoue O, Terasaki O et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 1997; 385: 634–636.
Pirker W, Asenbaum S, Wenger S, Kornhuber J, Angelberger P, Deecke L, Podreka I, Brücke T . Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease. J Nucl Med 1997; 38: 1711–1717.
Kaasinen V, Vilkman H, Hietala J, Någren K, Helenius H, Olsson H et al. Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol Aging 2000; 21: 683–688.
Inoue M, Suhara T, Sudo Y, Okubo Y, Yasuno F, Kishimoto T et al. Age-related reduction of extrastriatal dopamine D2 receptors measured by PET. Life Sci 2001; 69: 1079–1084.
Cohen J . Statistical Power Analysis for the Behavioral Sciences. Academic Press Inc.: Orlando, FL, 1977.
Acknowledgements
The study was supported by funding of Annual EVO Financing (Special government subsidies, Kuopio University Hospital) and by the grant from the Foundation for Psychiatric Research, Finland. We thank Pirjo Halonen, MSc, for statistical advice and Aija Räsänen for secretarial assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tuppurainen, H., Kuikka, J., Viinamäki, H. et al. Extrastriatal dopamine D2/3 receptor density and distribution in drug-naive schizophrenic patients. Mol Psychiatry 8, 453–455 (2003). https://doi.org/10.1038/sj.mp.4001334
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001334
Keywords
This article is cited by
-
In vivo absolute quantification of striatal and extrastriatal D2/3 receptors with [123I]epidepride SPECT
EJNMMI Research (2020)
-
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment
Psychopharmacology (2009)
-
Dopamine hypothesis of schizophrenia: Making sense of it all
Current Psychiatry Reports (2007)
-
The Striatal and Extrastriatal D2/D3 Receptor-Binding Profile of Clozapine in Patients with Schizophrenia
Neuropsychopharmacology (2006)